Tablets & Capsules


Issue link:

Contents of this Issue


Page 19 of 67

AAPS PharmSci360 a preview Annual AAPS meeting expected to draw more than 7,000 scientists system pharmacology, and bioanalyt- ical method validation. The conference officially starts on Sunday at 5:00 pm with an opening plenary session, followed by a wel- come reception. Speakers include J. Craig Venter, co-founder and chief executive officer of Human Longev- ity, a genomics-based health intelli- gence company, and Dr. Stephen Grupp, director of the cancer immu- notherapy program at the Children's Hospital of Philadelphia. Partial Exhibitors List The following companies and organizations are among those exhibiting at PharmSci360. For a complete, updated list, visit www. Company Booth Abitec 2618 Advantest 1704 Alcami 1719 Ametek Brookfield 1335 Beckman Coulter 408 Biddle Sawyer 2342 Bosch Packaging Technology 1409 Buchi 2509 Budenheim 2536 Catalent Pharma Solutions 1727 CfPA 1503 CMIC 509 Chartwell Pharmaceuticals 2831 PharmSci360, the annual meeting of the American Association of Phar- maceutical Scientists (AAPS), will take place November 4-7 in Wash- ington, DC. More than 7,000 scien- tists and other pharmaceutical pro- fessionals are expected to attend as well as hundreds of exhibitors, including big and small pharmaceuti- cal manufacturers, CDMOs, and R&D companies. Education This year's conference will feature programming about chemical and biomolecular drugs and will specifi- cally focus on preclinical develop- ment, bioanalytics, clinical pharma- cology, manufacturing and biopro- cessing, and formulation and quality. Visitors can attend several educa- tional panels and poster sessions pre- sented by scientists from various uni- versities, pharmaceutical companies, and regulatory organizations from around the world. On Saturday and Sunday, attend- ees have the option to participate in day-long short courses for an addi- tional fee. Some of the topics cov- ered in these sessions include the development of fixed-dose combina- tion products, surfactants and bio- pharmaceuticals, developing generic drug products, regulatory submis- sions, risk assessment for biologic proteins and peptides, quantitative Coating Place 1929 Colorcon 2427 CoreRx 2318 Covance 401, 2000 Distek 927 Driam USA 1938 Freund-Vector 1827 Frewitt USA 2034 Gattefosse USA 1300 Halo Labs 2511 Hovione 2309 IMA SPA 2037 IPEC-Americas 2428 JRS Pharma 2209 Lonza Pharma & Biotech 2200 Lubrizol LifeSciences 2319 MG America 1615 Netzsch 1700, 2834 Omya 2537 PCI Pharma Services 1901 Particle Sizing Systems 1114 Patheon 2501 Pharmaceutics International 2030 Qualicaps 1103 Recro Gainesville 1936 Renishaw 2820 Rigaku Americas 1336 Roquette 1939 Rottendorf Pharma 1535 SafeBridge Consultants 1614 Shimadzu 1100 Shin-Etsu 2137 18 October 2018 Tablets & Capsules

Articles in this issue

Links on this page

Archives of this issue

view archives of Tablets & Capsules - TC1018